| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:Tadocizumab (anti-Integrin α2β3)
CAS:339086-80-5
Purity:ExactAb?, Validated, Carrier Free, Low Endotoxin, Azide Free Package:100μg Remarks:K14222
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Tadocizumab
CAS:339086-80-5
Purity:95% Package:100ug;500ug;1mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:Tadocizumab
CAS:339086-80-5
Package:1mg/RMB 2980;5mg/RMB 6820;10mg/RMB 9180
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
| Products Intro: |
Product Name:Research Grade Tadocizumab (DHC33303)
CAS:339086-80-5
Purity:PAGE:>95% Package:100ug;1mg
|
|
| | tadocizumab Basic information |
| Product Name: | tadocizumab | | Synonyms: | tadocizumab;Research Grade Tadocizumab (DHC33303);Research Grade Tadocizumab;Tadocizumab (anti-Integrin α2β3) | | CAS: | 339086-80-5 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![tadocizumab Structure]() |
| | tadocizumab Chemical Properties |
| | tadocizumab Usage And Synthesis |
| Uses | Treatment of patients undergoing percutaneous coronary interventions. | | in vivo | Tadocizumab (YM-337; C4G1) dose-dependently inhibits ex vivo platelet aggregation, with complete inhibition at doses higher than 0.25 mg/kg intravenous injection or 1.5 μg/kg/min infusion in rhesus monkeys[1].
Tadocizumab (YM-337; C4G1) at a dose of 1 mg/kg intravenous injection followed by 6 μg/kg/min infusion for 60 min prevented occlusive thrombus formation in monkeys, in a photochemically-induced thrombosis model in squirrel monkeys[1]. | | IC 50 | GPIIb/IIIa |
| | tadocizumab Preparation Products And Raw materials |
|